Licenses. Except in the event of # termination by Licensee for an uncured material breach by Ovid, or # termination by Licensee in the circumstances set forth in Section 14.2(b)(i) with respect to Ovid, or # Ovid’s termination for Safety Reason, the licenses granted by Licensee to Ovid shall survive such termination and shall automatically become worldwide. All of the licenses granted by Ovid to Licensee shall be automatically terminated.

Licenses. Keep each material License affecting any Collateral (including the manufacture, distribution or disposition of Inventory) or any other material Property of Borrowers and Subsidiaries in full force and effect and pay all Royalties when due, except to the extent such License is replaced by a License that is comparable or more favorable to Borrowers or such License matures or expires in accordance with the terms of such License.

Licenses. Keep each material License affecting any Collateral (including the manufacture, distribution or disposition of Inventory) or any other material Property of Obligors and Subsidiaries in full force and effect, except where the failure to keep a License in full force and effect would not reasonably have a Material Adverse Effect; promptly notify Agent of any proposed modification to any such License, or entry into any new material License affecting any Collateral (including the manufacture, distribution or disposition of Inventory) or any other material Property of Obligors, in each case promptly after the effective date therefor; pay all royalties and other amounts when due under any such License; and notify Agent of any material default or breach asserted by any Person to have occurred under any such License.

Licenses. Except in the event of # termination by Licensee for an uncured material breach by Ovid, or # termination by Licensee in the circumstances set forth in Section 14.2(b)(i) with respect to Ovid, or # Ovid’s termination for Safety Reason, the licenses granted by Licensee to Ovid shall survive such termination and shall automatically become worldwide. All of the licenses granted by Ovid to Licensee shall be automatically terminated.

Licenses. All licenses granted hereunder will terminate; provided that such licenses will continue as necessary for the Parties to complete the orderly wind-down of their activities under this Agreement in accordance with Applicable Laws and as otherwise required in accordance with [Section 15.6(a)(ii)]. With the exception of such wind-down activities, each Party shall immediately cease and shall cause its Affiliates, Sublicensees and subcontractors, each as applicable, to immediately cease, all Development, Manufacturing and Commercialization [[Person A:Person]] activities hereunder. In the event of termination of this Agreement with respect to a Program pursuant to Section 15.2 by Acadia or Section 15.4 by Stoke, all Results pertaining to the Program shall be deemed the Confidential Information of Stoke.

Licenses. Verrica shall and hereby does grant to Lytix a royalty-free, fully paid-up, exclusive (even as to Verrica and its Affiliates), perpetual, irrevocable license (with the right to grant sublicenses through multiple tiers) under Verrica Inventions to research, Develop, make, have made, use, sell, have sold, offer for sale, import, and otherwise Commercialize Product in the Retained Field in the Territory, subject to the terms and conditions of this Agreement.

Licenses. Keep each material License affecting any Collateral (including the manufacture, distribution or disposition of Inventory) or any other material Property of Borrowers and Subsidiaries in full force and effect and pay all Royalties when due, except to the extent such License is replaced by a License that is comparable or more favorable to Borrowers or such License matures or expires in accordance with the terms of such License.

Licenses. The License and all other rights granted by NVCR to Zai under the NVCR IP and copyrights and trademarks owned or Controlled by NVCR shall terminate and all sublicenses granted by Zai shall also terminate.

Licenses. Keep each material License affecting any Collateral of Borrowers and Subsidiaries in full force and effect, except as could not reasonably be expected to have a Material Adverse Effect.

Licenses. Bausch Health hereby grants to Clearside, effective upon such termination, a non-exclusive, worldwide, sublicensable (through multiple tiers) license, under any Bausch Health IP, to Develop, Manufacture, have Manufactured, Commercialize and otherwise use and exploit Products. The license under this [Section 13.3(e)] (i) will have no payments associated with the license for XIPERE Products and # will be royalty-bearing (but will have no other associated payments) for the license for Other Products. The royalty rate for Other Products will be ​, and royalties will be calculated, paid and reported in accordance with Article 8 and related defined terms, mutatis mutandis.